Funded Biotechnology Startups in Bangalore
The 14 rounds tracked here span from May 2021 through January 2025, with Bangalore accounting for all entries across a range of biotech sub-sectors.
The 14 rounds tracked here span from May 2021 through January 2025, with Bangalore accounting for all entries across a range of biotech sub-sectors. Seed-stage deals are the most frequent round type — five of the 14 — with BrainSightAI's $5M close in January 2025 and Algorithmic Biologics' $3M round in February 2024 among the most recent. Activity accelerated noticeably in the 12 months through early 2025, with BUGWORKS Research ($7M), Mynvax ($3M Series A), and Biodimension Technology ($140K Angel) all closing in 2024.
The two largest disclosed amounts belong to MedGenome ($50M, August 2022) and PlasmaGen Biosciences ($27M, December 2023), both carrying undisclosed or unknown series labels. String Bio and Sea6 Energy represent the only fully labeled Series B rounds in the set, at $20M and $10M respectively, both closing within weeks of each other in mid-2022. BrainSightAI is the only company to appear twice, with a $120K raise in July 2023 preceding its $5M Seed in January 2025.
Most recent rounds
14 shownRelated listings
Frequently asked
What are the largest disclosed rounds among these Bangalore biotech companies?
MedGenome leads at $50M (Venture - Series Unknown, August 2022), followed by PlasmaGen Biosciences at $27M (Series Unknown, December 2023) and String Bio at $20M (Series B, July 2022). Both top rounds carry undisclosed or unspecified series labels, a recurring pattern across this dataset.
Which funding stage appears most frequently in this set?
Seed is the most common stage, accounting for five of the 14 rounds. Companies include BrainSightAI ($5M, January 2025), Algorithmic Biologics ($3M, February 2024), altM ($4M, September 2023), NKure Therapeutics (undisclosed, April 2023), and Phyx44 Labs ($1M, November 2022).
Has any company raised multiple rounds in this dataset?
BrainSightAI appears twice — a $120K Series Unknown round in July 2023 and a $5M Seed round in January 2025, suggesting the earlier entry may reflect a pre-seed or bridge close prior to the larger raise.
How active has Bangalore biotech fundraising been in 2024 and 2025?
Four rounds closed in 2024: BrainSightAI ($5M Seed, January 2025 is the only 2025 entry), Biodimension Technology ($140K Angel, October 2024), Mynvax ($3M Series A, May 2024), BUGWORKS Research ($7M, March 2024), and Algorithmic Biologics ($3M Seed, February 2024) — meaning five of the 14 rows fall within a 13-month window ending January 2025.
What biotech sub-sectors do these companies cover?
The 14 companies span neuroscience diagnostics (BrainSightAI), vaccine development (Mynvax), anti-infectives (BUGWORKS Research), plasma-derived biologics (PlasmaGen Biosciences), genomics services (MedGenome), seaweed-based bioenergy (Sea6 Energy, String Bio), and cell therapeutics (NKure Therapeutics), indicating broad sub-sector diversity within a single city cluster.
Are there transparency gaps in round type or amount disclosures?
Two companies — BUGWORKS Research ($7M, March 2024) and Artivatic.ai ($1M, May 2021) — have no round type listed. NKure Therapeutics closed a Seed round in April 2023 with no amount disclosed. Several others are labeled Series Unknown, limiting precise stage-based filtering.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.